Inversago Pharma Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 21

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $1.07B

Inversago Pharma General Information

Description

Developer of medical drugs designed to treat patients suffering from metabolic and fibrotic disorders. The company's drugs are developed by using peripherally-restricted cannabinoid receptor agonists of type 1 receptor and used to cure non-alcoholic fatty liver disease and obesity, enabling healthcare professionals and patients to receive new-generation drugs for the treatment of metabolic diseases.

Contact Information

Website
www.inversago.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 1100 René-Lévesque Boulevard West
  • Suite 1110
  • Montreal, Quebec H3B 4N4
  • Canada
+1 (438)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Parent Company
Novo Nordisk
Vertical(s)
Life Sciences
Corporate Office
  • 1100 René-Lévesque Boulevard West
  • Suite 1110
  • Montreal, Quebec H3B 4N4
  • Canada
+1 (438)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Inversago Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 08-Sep-2023 $1.07B Completed Clinical Trials - Phase 2
3. Later Stage VC (Series C) 14-Oct-2022 Completed Clinical Trials - Phase 2
2. Later Stage VC (Series B) 08-Sep-2020 $35M $40.3M Completed Clinical Trials - Phase 1
1. Early Stage VC (Series A) 25-Jul-2018 $5.32M $5.32M Completed Pre-Clinical Trials
To view Inversago Pharma’s complete valuation and funding history, request access »

Inversago Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of medical drugs designed to treat patients suffering from metabolic and fibrotic disorders. The company's dru
Drug Discovery
Montreal, Canada
21 As of 2024

Chadds Ford, PA

Copenhagen, Denmark
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Inversago Pharma Competitors (19)

One of Inversago Pharma’s 19 competitors is Jenrin Discovery, a Venture Capital-Backed company based in Chadds Ford, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Jenrin Discovery Venture Capital-Backed Chadds Ford, PA
Galecto Formerly VC-backed Copenhagen, Denmark
Cardurion Venture Capital-Backed Burlington, MA
Gilead Sciences Formerly VC-backed Foster City, CA
Attgeno Venture Capital-Backed Solna, Sweden
You’re viewing 5 of 19 competitors. Get the full list »

Inversago Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Inversago Pharma Former Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
AQC Capital Venture Capital Minority
Accel-Rx Accelerator/Incubator Minority
Amgen Ventures Corporate Venture Capital Minority
AmorChem Venture Capital Minority
Anges Québec VC-Backed Company Minority
You’re viewing 5 of 14 investors. Get the full list »

Ready to get started?

Request a free trial

Inversago Pharma FAQs

  • When was Inversago Pharma founded?

    Inversago Pharma was founded in 2015.

  • Where is Inversago Pharma headquartered?

    Inversago Pharma is headquartered in Montreal, Canada.

  • What is the size of Inversago Pharma?

    Inversago Pharma has 21 total employees.

  • What industry is Inversago Pharma in?

    Inversago Pharma’s primary industry is Drug Discovery.

  • Is Inversago Pharma a private or public company?

    Inversago Pharma is a Private company.

  • What is the current valuation of Inversago Pharma?

    The current valuation of Inversago Pharma is .

  • What is Inversago Pharma’s current revenue?

    The current revenue for Inversago Pharma is .

  • How much funding has Inversago Pharma raised over time?

    Inversago Pharma has raised $110M.

  • Who are Inversago Pharma’s investors?

    AQC Capital, Accel-Rx, Amgen Ventures, AmorChem, and Anges Québec are 5 of 14 investors who have invested in Inversago Pharma.

  • Who are Inversago Pharma’s competitors?

    Jenrin Discovery, Galecto, Cardurion, Gilead Sciences, and Attgeno are some of the 19 competitors of Inversago Pharma.

  • When was Inversago Pharma acquired?

    Inversago Pharma was acquired on 08-Sep-2023.

  • Who acquired Inversago Pharma?

    Inversago Pharma was acquired by Novo Nordisk.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »